These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 21751892)
1. Pharmacology of intravenous insulin administration: implications for future closed-loop glycemic control by the intravenous/intravenous route. Skjaervold NK; Lyng O; Spigset O; Aadahl P Diabetes Technol Ther; 2012 Jan; 14(1):23-9. PubMed ID: 21751892 [TBL] [Abstract][Full Text] [Related]
2. Intravenous bolus insulin delivery: implications for closed-loop control and hospital care. Hirsch IB Diabetes Technol Ther; 2012 Jan; 14(1):6-7. PubMed ID: 21992271 [No Abstract] [Full Text] [Related]
3. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial. Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323 [TBL] [Abstract][Full Text] [Related]
4. A feasibility study of bihormonal closed-loop blood glucose control using dual subcutaneous infusion of insulin and glucagon in ambulatory diabetic swine. El-Khatib FH; Jiang J; Damiano ER J Diabetes Sci Technol; 2009 Jul; 3(4):789-803. PubMed ID: 20144330 [TBL] [Abstract][Full Text] [Related]
5. Strict glycemic control in diabetic dogs with closed-loop intraperitoneal insulin infusion algorithm designed for an artificial endocrine pancreas. Matsuo Y; Shimoda S; Sakakida M; Nishida K; Sekigami T; Ichimori S; Ichinose K; Shichiri M; Araki E J Artif Organs; 2003; 6(1):55-63. PubMed ID: 14598126 [TBL] [Abstract][Full Text] [Related]
6. Closed-loop glycaemic control using an implantable artificial pancreas in diabetic domestic pig (Sus scrofa domesticus). Taylor MJ; Gregory R; Tomlins P; Jacob D; Hubble J; Sahota TS Int J Pharm; 2016 Mar; 500(1-2):371-8. PubMed ID: 26691655 [TBL] [Abstract][Full Text] [Related]
7. Comparison between closed-loop portal and peripheral venous insulin delivery systems for an artificial endocrine pancreas. Sekigami T; Shimoda S; Nishida K; Matsuo Y; Ichimori S; Ichinose K; Shichiri M; Sakakida M; Araki E J Artif Organs; 2004; 7(2):91-100. PubMed ID: 15309676 [TBL] [Abstract][Full Text] [Related]
8. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial. Haidar A; Legault L; Dallaire M; Alkhateeb A; Coriati A; Messier V; Cheng P; Millette M; Boulet B; Rabasa-Lhoret R CMAJ; 2013 Mar; 185(4):297-305. PubMed ID: 23359039 [TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamics and stability of subcutaneously infused glucagon in a type 1 diabetic Swine model in vivo. El-Khatib FH; Jiang J; Gerrity RG; Damiano ER Diabetes Technol Ther; 2007 Apr; 9(2):135-44. PubMed ID: 17425438 [TBL] [Abstract][Full Text] [Related]
10. Run-to-run tuning of model predictive control for type 1 diabetes subjects: in silico trial. Magni L; Forgione M; Toffanin C; Dalla Man C; Kovatchev B; De Nicolao G; Cobelli C J Diabetes Sci Technol; 2009 Sep; 3(5):1091-8. PubMed ID: 20144422 [TBL] [Abstract][Full Text] [Related]
11. The effect of insulin therapy algorithms on blood glucose levels in patients following cardiac surgery: A systematic review. Higgs M; Fernandez R JBI Database System Rev Implement Rep; 2015 Jun; 13(5):205-43. PubMed ID: 26455610 [TBL] [Abstract][Full Text] [Related]
13. [What is the current state of the artificial pancreas in diabetes care?]. Dimou M; Laimer M; Stettler C; Bally L Internist (Berl); 2020 Jan; 61(1):102-109. PubMed ID: 31863132 [TBL] [Abstract][Full Text] [Related]
14. Closed-loop insulin delivery using a subcutaneous glucose sensor and intraperitoneal insulin delivery: feasibility study testing a new model for the artificial pancreas. Renard E; Place J; Cantwell M; Chevassus H; Palerm CC Diabetes Care; 2010 Jan; 33(1):121-7. PubMed ID: 19846796 [TBL] [Abstract][Full Text] [Related]
15. A bio-inspired glucose controller based on pancreatic β-cell physiology. Herrero P; Georgiou P; Oliver N; Johnston DG; Toumazou C J Diabetes Sci Technol; 2012 May; 6(3):606-16. PubMed ID: 22768892 [TBL] [Abstract][Full Text] [Related]
16. Fluctuations of Hyperglycemia and Insulin Sensitivity Are Linked to Menstrual Cycle Phases in Women With T1D. Brown SA; Jiang B; McElwee-Malloy M; Wakeman C; Breton MD J Diabetes Sci Technol; 2015 Oct; 9(6):1192-9. PubMed ID: 26468135 [TBL] [Abstract][Full Text] [Related]
17. Software-guided insulin dosing improves intrapartum glycemic management in women with diabetes mellitus. Dinglas C; Muscat J; Adams T; Peragallo-Dittko V; Vintzileos A; Heo HJ Am J Obstet Gynecol; 2018 Aug; 219(2):191.e1-191.e6. PubMed ID: 29750952 [TBL] [Abstract][Full Text] [Related]
18. The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability. Anderson SM; Dassau E; Raghinaru D; Lum J; Brown SA; Pinsker JE; Church MM; Levy C; Lam D; Kudva YC; Buckingham B; Forlenza GP; Wadwa RP; Laffel L; Doyle FJ; DeVries JH; Renard E; Cobelli C; Boscari F; Del Favero S; Kovatchev BP Diabetes Technol Ther; 2019 Feb; 21(2):73-80. PubMed ID: 30649925 [TBL] [Abstract][Full Text] [Related]
19. Glycemic control with closed-loop intraperitoneal insulin in type I diabetes. LeBlanc H; Chauvet D; Lombrail P; Robert JJ Diabetes Care; 1986; 9(2):124-8. PubMed ID: 3516606 [TBL] [Abstract][Full Text] [Related]
20. Diabetes technology and treatments in the paediatric age group. Shalitin S; Peter Chase H Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]